Oramed Pharmaceuticals (ORMP) Revenue (2016 - 2025)

Oramed Pharmaceuticals (ORMP) posted Revenue of $2.0 million for Q1 2025, up 196.74% on a QoQ basis from $674000.0 in Q2 2023.

Oramed Pharmaceuticals (ORMP) Revenue (2016 - 2025) Analysis & Trends

Oramed Pharmaceuticals' Revenue history runs 8 years deep, the most recent figure standing at $2.0 million for Q1 2025.

  • Quarterly Revenue changed N/A year-over-year to $2.0 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $2.0 million (changed N/A YoY) and the FY2025 annual result came in at $2.0 million, changed N/A from the prior year.
  • Revenue was $2.0 million for Q1 2025 at Oramed Pharmaceuticals, up from $674000.0 in the prior quarter.
  • Across five years, Revenue topped out at $2.7 million in Q3 2021 and bottomed at $666000.0 in Q1 2022.
  • A 4-year average of $1.1 million and a median of $678000.0 in 2022 frame the typical range for Revenue.
  • Peak annual rise in Revenue reached 0.0% in 2023, while the deepest fall reached 0.0% in 2023.
  • Oramed Pharmaceuticals' Revenue stood at $2.7 million in 2021, then sank by 66.56% to $904000.0 in 2022, then decreased by 25.44% to $674000.0 in 2023, then jumped by 196.74% to $2.0 million in 2025.
  • Business Quant data shows ORMP's Revenue at $2.0 million in Q1 2025, $674000.0 in Q2 2023, and $666000.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.51 Bn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.56 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Oramed Pharmaceuticals 170.25 Mn 170.25 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 2.00 Mn
Jun 30, 2023 674,000.00
Mar 31, 2023 666,000.00
Dec 31, 2022 904,000.00
Sep 30, 2022 682,000.00
Jun 30, 2022 674,000.00
Mar 31, 2022 666,000.00
Aug 31, 2021 2.70 Mn
Nov 30, 2019 674,000.00
Aug 31, 2019 681,000.00
May 31, 2019 682,000.00
Feb 28, 2019 666,000.00
Nov 30, 2018 674,000.00
Aug 31, 2018 617,000.00
May 31, 2018 617,000.00
Feb 28, 2018 604,000.00
Nov 30, 2017 611,000.00
Aug 31, 2017 618,000.00
May 31, 2017 617,000.00
Feb 28, 2017 611,000.00